Obalon Therapeutics Inc (OBLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OBLN | TMO | ISRG | EW | FMS |
| Company | Obalon Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Fresenius Medical Care Ag ADR |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 9.75 | 579.84 | 380.00 | 85.85 | 21.46 |
| High | 14.40 | 579.84 | 384.47 | 86.95 | 21.57 |
| Low | 8.84 | 571.63 | 378.87 | 85.20 | 20.97 |
| Last | 9.15 | 572.38 | 381.36 | 85.25 | 20.97 |
| Change | -0.57 | +1.13 | +3.71 | +0.19 | -0.69 |
| % Change | -5.86% | +0.20% | +0.98% | +0.22% | -3.19% |
| Volume | 8,927,233 | 1,749,600 | 1,028,800 | 2,327,100 | 494,700 |
| 20-Day Average Volume | 7,631,245 | 1,437,555 | 1,473,430 | 2,989,750 | 400,355 |
| Previous Close | 9.72 | 571.25 | 377.65 | 85.06 | 21.66 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.23 | 566.87 | 377.87 | 88.02 | 19.93 |
| 20-Day Raw Stochastic | 27.38% | 70.89% | 60.04% | 18.21% | 79.10% |
| 20-Day Relative Strength | 49.61% | 51.63% | 51.12% | 41.97% | 57.12% |
| Weighted Alpha | -38.05 | +8.72 | +27.65 | +1.47 | -6.70 |
| Today's Opinion | 40% Buy | 56% Buy | 56% Buy | 40% Buy | 24% Buy |
| Previous Opinion | 56% Buy | 56% Buy | 40% Buy | 40% Buy | 24% Buy |
| Last Month's Opinion | 16% Sell | 80% Buy | 64% Buy | 80% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.68% since 06/08/21 | -0.21% since 04/26/24 | +1.61% since 04/26/24 | -1.37% since 04/26/24 | +4.33% since 04/26/24 |
| Low | 2.95 on 06/15/21 | 565.49 on 05/02/24 | 367.39 on 05/02/24 | 83.50 on 05/01/24 | 20.41 on 04/29/24 |
| High | 4.80 on 06/15/21 | 581.90 on 05/01/24 | 384.47 on 05/03/24 | 87.21 on 04/29/24 | 21.67 on 05/02/24 |
| 1-Month | |||||
| %Chg | +27.62% since 05/14/21 | -0.63% since 04/03/24 | -0.54% since 04/03/24 | -8.35% since 04/03/24 | +11.36% since 04/03/24 |
| Low | 2.26 on 05/17/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 18.32 on 04/12/24 |
| High | 4.88 on 05/24/21 | 589.93 on 04/09/24 | 393.66 on 04/05/24 | 94.37 on 04/04/24 | 21.67 on 05/02/24 |
| 3-Month | |||||
| %Chg | -16.67% since 03/15/21 | +3.73% since 02/02/24 | -0.63% since 02/02/24 | -0.98% since 02/02/24 | +8.54% since 02/02/24 |
| Low | 1.95 on 05/06/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 82.53 on 02/07/24 | 18.32 on 04/12/24 |
| High | 4.88 on 05/24/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.67 on 05/02/24 |
| 6-Month | |||||
| %Chg | +98.03% since 12/15/20 | +25.87% since 11/03/23 | +36.92% since 11/03/23 | +27.11% since 11/03/23 | +20.31% since 11/03/23 |
| Low | 1.38 on 01/06/21 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 16.66 on 11/07/23 |
| High | 10.77 on 01/20/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 21.67 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,567 | 218,485,456 | 135,270,672 | 51,371,648 | 12,305,762 |
| Shares Outstanding, K | 10,022 | 381,714 | 354,706 | 602,600 | 586,827 |
| Annual Sales | 1,590,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 21,054,650,000 |
| Annual Net Income | -12,330,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 540,060,000 |
| Last Quarter Sales | 60,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 5,371,060,000 |
| Last Quarter Net Income | -1,320,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 202,510,000 |
| 60-Month Beta | -1.23 | 0.80 | 1.39 | 1.10 | 0.95 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.47 on 02/20/24 |
| Latest Earnings Date | 07/29/21 | 04/24/24 | 04/18/24 | 04/25/24 | 05/14/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | 0.415 on 05/17/23 |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | 05/17/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.42 | 80.69 | 33.36 | 15.70 |